When a Facebook, Uber, or Airbnb of health care looks elusive

Okay, I used these big names in the headline to grab some attention. That said, few would disagree that there’s dire need for such unicorns to emerge in health care so that the benefits of network conditions make health care less expensive, more effective, and above all, participatory in managing chronic illnesses. One could argue […]

Biocon-Pfizer Breakup: Why Diabetes Alliances Don’t Work for Indian pharma?

In a very surprising move, Pfizer and Biocon announced today that they have called off their 17-month old commercialization alliance for generic insulin. “The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently,” said the press release. This was followed […]

Biocon-Pfizer Breakup: Why Diabetes Alliances Don't Work for Indian pharma?

In a very surprising move, Pfizer and Biocon announced today that they have called off their 17-month old commercialization alliance for generic insulin. “The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently,” said the press release. This was followed […]